Send me a link:

*Text messaging rates may apply.

 Dow Up0.17% Nasdaq Up0.44%

Jazz Pharmaceuticals Public Limited Company (JAZZ)

-NasdaqGS
150.80 1.69(1.11%) Jul 11, 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2014Dec 31, 2013Sep 30, 2013Jun 30, 2013
Total Revenue 246,919   235,774   232,160   208,252  
Cost of Revenue30,924  25,643  24,252  25,031  
Gross Profit 215,995   210,131   207,908   183,221  
Operating Expenses
Research Development18,109  13,809  12,814  13,250  
Selling General and Administrative106,363  81,299  74,970  77,506  
Non Recurring127,000   -   -  (4,000)
Others31,182  20,524  19,564  19,399  
Total Operating Expenses282,654   -   -  106,155  
Operating Income or Loss (66,659) 94,499   100,560   77,066  
Income from Continuing Operations
Total Other Income/Expenses Net123  (969)(614)(4,134)
Earnings Before Interest And Taxes(66,536)93,530  99,946  72,932  
Interest Expense10,076  6,173  6,202  7,142  
Income Before Tax(76,612)87,357  93,744  65,790  
Income Tax Expense17,027  32,064  18,335  23,605  
Minority Interest989   -   -   -  
Net Income From Continuing Ops(92,650)55,293  75,409  42,185  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (92,650) 55,293   75,409   42,185  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (92,650) 55,293   75,409   42,185  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.